Bank Of Montreal Biotechnology

Bank Of Montreal

$214 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
RPTX Repare Therapeutics Inc.	$52M	$362,000 0.0% of portfolio	105,247	Q3 2024 Reduced 5.13%
ZLAB Zai Lab LTD	$2.61B	$335,000 0.0% of portfolio	13,900	Q1 2023 Added 178.09%
CCCC C4 Therapeutics, Inc.	$188M	$308,000 0.0% of portfolio	54,116	Q3 2024 Added 180.39%
INVA Innoviva, Inc.	$1.31B	$307,000 0.0% of portfolio	15,907	Q3 2024 Reduced 17.78%
CPRX Catalyst Pharmaceuticals, Inc.	$2.36B	$278,000 0.0% of portfolio	14,004	Q3 2024 Added 3.4%
PTGX Protagonist Therapeutics, Inc	$1.87B	$268,000 0.0% of portfolio	5,980	Q3 2024 New
CRSP Crispr Therapeutics Ag	$3.45B	$264,000 0.0% of portfolio	5,620	Q3 2024 Reduced 25.62%
ARWR Arrowhead Pharmaceuticals, Inc.	$2.09B	$256,000 0.0% of portfolio	13,259	Q3 2024 Reduced 69.66%
VERV Verve Therapeutics, Inc.	$394M	$243,000 0.0% of portfolio	50,270	Q3 2024 Reduced 3.96%
BBIO Bridge Bio Pharma, Inc.	$5.35B	$226,000 0.0% of portfolio	8,899	Q3 2024 Reduced 6.57%
VCEL Vericel Corp	$2.81B	$223,000 0.0% of portfolio	5,298	Q3 2024 Reduced 2.18%
REPL Replimune Group, Inc.	$584M	$152,000 0.0% of portfolio	13,889	Q3 2024 New
ABCL Ab Cellera Biologics Inc.	$1.01B	$150,000 0.0% of portfolio	58,013	Q3 2024 Added 39.26%
ACET Adicet Bio, Inc.	$37.6M	$113,000 0.0% of portfolio	78,704	Q3 2024 Added 529.43%
AVXL Anavex Life Sciences Corp.	$768M	$112,000 0.0% of portfolio	19,880	Q3 2024 Added 28.56%
LXRX Lexicon Pharmaceuticals, Inc.	$149M	$109,000 0.0% of portfolio	70,001	Q2 2024 Added 75.0%
ANVS Annovis Bio, Inc.	$41.2M	$108,000 0.0% of portfolio	13,500	Q3 2024 New
GERN Geron Corp	$1.12B	$108,000 0.0% of portfolio	23,870	Q3 2024 Added 2.14%
BCRX Biocryst Pharmaceuticals Inc	$1.42B	$104,000 0.0% of portfolio	13,723	Q2 2024 New
RPHM Reneo Pharmaceuticals, Inc.	$41.1M	$103,000 0.0% of portfolio	60,617	Q3 2024 Reduced 53.64%
ABEO Abeona Therapeutics Inc.	$30.5M	$90,000 0.0% of portfolio	14,300	Q3 2024 New
CRBU Caribou Biosciences, Inc.	$92.5M	$90,000 0.0% of portfolio	46,369	Q3 2024 New
VIR Vir Biotechnology, Inc.	$1.4B	$86,000 0.0% of portfolio	11,575	Q3 2024 Reduced 19.19%
NKTR Nektar Therapeutics	$169M	$70,000 0.0% of portfolio	54,502	Q3 2024 Added 0.0%
QURE Uni Qure N.V.	$697M	$70,000 0.0% of portfolio	14,300	Q3 2024 Added 21.6%
ADPT Adaptive Biotechnologies Corp	$1.06B	$66,000 0.0% of portfolio	13,023	Q3 2024 Reduced 2.1%
AVTE Aerovate Therapeutics, Inc.	$62.3M	$66,000 0.0% of portfolio	31,644	Q3 2024 New
PRQR Pro Qr Therapeutics N.V.	$161M	$54,000 0.0% of portfolio	30,000	Q4 2023 New
HRTX Heron Therapeutics, Inc.	$194M	$50,000 0.0% of portfolio	25,194	Q3 2024 New
HLVX Hille Vax, Inc.	$64.2M	$42,000 0.0% of portfolio	24,304	Q3 2024 New
LEXX Lexaria Bioscience Corp.	$11.8M	$42,000 0.0% of portfolio	14,000	Q3 2024 New
VTYX Ventyx Biosciences, Inc.	$118M	$38,000 0.0% of portfolio	17,702	Q3 2024 New
IPA Immuno Precise Antibodies Ltd.	$12.9M	$36,000 0.0% of portfolio	57,807	Q3 2024 Added 3.49%
ONCY Oncolytics Biotech Inc	$47.5M	$32,000 0.0% of portfolio	37,924	Q3 2024 Added 1.33%
LYRA Lyra Therapeutics, Inc.	$6.37M	$31,000 0.0% of portfolio	119,379	Q3 2024 New
VXRT Vaxart, Inc.	$96.1M	$12,000 0.0% of portfolio	15,125	Q1 2024 New
SGMO Sangamo Therapeutics, Inc	$177M	$10,000 0.0% of portfolio	12,057	Q3 2024 New
AMRN Amarin Corp Plcuk	$230M	$6,000 0.0% of portfolio	10,142	Q2 2024 Reduced 16.47%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.